Switch to:
More From Other Websites
Nektar/AstraZeneca's Moventig a Step Closer to EU Approval Sep 29 2014
7:32 am Nektar Therapeutics' MOVENTIG (naloxegol) receives positive CHMP opinion in EU for treatment... Sep 28 2014
Nektar Therapeutics Announces MOVENTIG® (naloxegol) Receives Positive CHMP Opinion In EU For... Sep 26 2014
Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at... Sep 19 2014
Nektar says FDA clears constipation drug Movantik Sep 16 2014
Nektar says FDA clears constipation drug Movantik Sep 16 2014
BUZZ-Nektar Therapeutics: FDA approves constipation drug Sep 16 2014
FDA Approves MOVANTIK™ (naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In... Sep 16 2014
FDA approves AstraZeneca, Nektar constipation drug Sep 16 2014
FDA approves AstraZeneca, Nektar constipation drug Sep 16 2014
Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life... Aug 21 2014
NEKTAR THERAPEUTICS Financials Aug 08 2014
Nektar's Loss Narrows in Q2, Beats Revenues, Retains View Aug 01 2014
NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report Aug 01 2014
NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 31 2014
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 Jul 31 2014
Q2 2014 NEKTAR THERAPEUTICS Earnings Release - After Market Close Jul 31 2014
Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After... Jul 22 2014
NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 27 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK